Mechanism of Action and Vascular Effects
The pharmacodynamics of pentoxifylline is based on its ability to block adenosine receptors and inhibit the enzyme phosphodiesterase (PDE). This leads to a significant intracellular accumulation of cyclic adenosine monophosphate (cAMP) in the smooth muscle cells of the vascular wall.
The result of this biochemical cascade is muscle relaxation and moderate dilation of the blood vessel lumen. Chemically, the active substance belongs to xanthine derivatives and shows clear structural similarity to theophyllinum (theophylline).
Hemorheological Effects and Microcirculation
In addition to its direct effect on vascular tone, the drug fundamentally alters blood rheological parameters (fluidity). PDE blockade and increased intracellular cAMP levels in platelets lead to a drop in cytoplasmic ionized calcium ($Ca^{2+}$) levels. Consequently, platelet aggregation is significantly inhibited.
A critically important effect is the increased deformability of erythrocytes. The improved elasticity of red blood cell membranes allows them to pass more easily through narrow capillaries. Together, these processes lead to:
- A marked decrease in blood viscosity.
- Normalization of microcirculation.
- Optimization of tissue oxygen delivery.
Parenteral (intravenous) administration also stimulates collateral blood flow, increasing volumetric circulation speed. Additionally, a metabolic effect is achieved, manifested by an increase in ATP content in brain neurons.
Indications and Dosage Regimens
The main indications for prescribing the drug are ischemic circulatory disorders of various etiologies. The medication acts across three key vascular beds:
- Cerebral.
- Coronary.
- Peripheral.
The agent is also actively used for vascular pathologies of the eye.
- Oral administration: Enteric-coated tablets are taken orally after meals. They must be swallowed whole without chewing, washed down with plenty of water. Standard formulations are prescribed 3 times daily, prolonged-release formulations 2 times daily.
- Parenteral administration: Intravenous drip infusions are used as needed, typically in severe disease states.
Side Effects and Symptoms of Overdose
Therapy with xanthine derivatives can be accompanied by several adverse events across various body systems:
- Cardiovascular system and skin: Tachycardia, a sharp drop in blood pressure (especially with IV administration), a feeling of warmth, and flushing of the face and upper chest. There is a risk of bleeding from mucous membrane and skin vessels.
- Gastrointestinal tract: Dyspeptic disorders, including nausea and vomiting.
- Central nervous system: Dizziness.
- Immune system: Allergic reactions.
Important: Similar to dipyridamole, pentoxifylline can provoke coronary steal syndrome, clinically manifested as acute angina attacks.
In overdose, patients may develop critical hypotension, hyperthermia, loss of consciousness, seizures, and massive gastrointestinal bleeding. Emergency care includes gastric lavage, administration of enteral sorbents (activated charcoal), and supportive management of vital functions (respiration and blood pressure).
Place in Vasodilator Classification
Cerebral circulation-improving drugs are divided into several pharmacological groups. Pentoxifylline is the primary representative of the xanthine derivative class. For comparison, clinical practice also utilizes:
- Vinca alkaloid derivatives (e.g., vinpocetine, which does not cause steal syndrome);
- Ergot alkaloid derivatives (nicergoline with combined alpha-blocking and myotropic action);
- Nicotinic acid derivatives (xanthinol nicotinate, combining vitamin and theophylline properties);
- Calcium channel blockers (cinnarizine) and GABA derivatives.
Familiarity with this classification allows physicians to individually select optimal angioprotective therapy based on the underlying pathology.